Use of New-to-Market Neurologic Medications Reported to Be Low
WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- Utilization of new-to-market neurologic medications in the privately insured population remains low, according to a study published onl…
WEDNESDAY, Nov. 30, 2022 (HealthDay News) -- Utilization of new-to-market neurologic medications in the privately insured population remains low, according to a study published onl…